News Article | May 5, 2017
— Market Highlights Changing preferences of the direct consumption choice by the consumer, especially dark chocolate which is considered to be healthy, has application in various confectionaries and dairy products is driving real chocolate sales. Globally, there has been increase in preferences for the fat-free and healthy food products by the consumers. Major real chocolate companies are tapping into people's growing health and wellness concerns by improving the nutritional profile of its chocolates portfolio. global real and compound chocolate market has been estimated to grow CAGR over 7% post 2022 Major companies have also invested in vending machines, so as to create awareness, advertise new products, and also to get feedback from the consumers. Among major applications of compound chocolate, choco-dipped strawberries has gained higher demand which has increased the potential growth of compound chocolate. Key Players • Hershey's (U.S.) • Ferrero (Italy) • Nestlé (Switzerland), • Domingo Ghirardelli (U.S.) • Lindt & Sprungli (Switzerland) • Scharffen Berger (U.S.) • Lotte (Japan) • Meiji Seika Kaisha Ltd. (Japan) • Fuji Oil Co., Ltd (Japan) • Barry Callebaut (Switzerland) Overall, increasing industrial demand from confectionery, chocolate processing bakery foods, and beverages will have a positive impact on the global real and compound chocolate market. Hence, the global real and compound chocolate market has been estimated to grow over 7% post 2022. Market Research Analysis: • Rapid innovation in the compound chocolate products inclusion of various flavors, application-specific products like choco-chips, chocolate syrup are driving the compound chocolate market • Real Chocolate is generally considered as premium chocolate, has led to innovation in various formats like low sugar, fortified chocolate, and etc. has also supported the real chocolate market to a greater extent Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Real and Compound Chocolate Market Research Report- Forecast to 2022” The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions. Table of Content 1 Executive Summary 2 Market Introduction 2.1 Definition 2.2 Scope of the study 2.2.1 Research Objectives 2.2.2 Assumptions 2.2.3 Limitations 2.3 Markets Structure 3 Research methodology 3.1 Research process 3.2 Secondary research 3.3 Primary research 3.4 Forecast model 3.5 Market Size estimation 4 Market Dynamics 4.1 Drivers 4.2 Restraints 4.3 Opportunities 4.4 Challenges 5 Market Trends 6 Market Factor Analysis Continue…….. List of Tables Table 1 Pestle Analysis-U.S Table 2 Pestle Analysis- India Table 3 Pestle Analysis- China Table 4 Pestle Analysis- Japan Table 5 Pestle Analysis- Germany Table 6 Key Suppliers Of Raw Materials For Functional Beverages Production Continue…… List of Figures Figure 1 Research Methodology Figure 2 Primary Data Analysis Approach Figure 3 Secondary Data Analysis Approach Figure 4 Trend In Functional Beverages Imports 2011-15 Figure 5 Growth Rate In Functional Beverages Imports 2011-15 Figure 6 Functional Beverages Imports Market Share By Top 5 Importers (2011 Vs 2015) Continue…… Related Report Global Savory Ingredients Market Information- by Product Type (Ribonucleotides, Monosodium Glutamate, Yeast Extracts, Hydrolyzed Animal Protein), by Ingredient Type, by Wellness Perspective, by Application and by Region - Forecast to 2022. Know more about this report @ https://www.marketresearchfuture.com/reports/savory-ingredients-market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. For more information, please visit https://www.marketresearchfuture.com
Meiji Seika Kaisha Ltd. and Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Date: 2013-07-12
A caprazene compound is provided which is the compound represented by the following formula (Ia): wherein Me stands for methyl group, and A is a hydrogen atom, and wherein said compound has the ^(1)H-NMR and ^(13)C-NMR data as set forth in Table 15.
Taisho Pharmaceutical Co. and Meiji Seika Kaisha Ltd. | Date: 2011-02-23
A 10a-azalide compound having a 4-membered ring structure crosslinked at the 10a- and 12-positions, which is represented by the formula (I), and is effective on even Haemophilus influenzae, or erythromycin resistant bacteria (e.g., resistant pneumococci and streptococci).
Meiji Seika Kaisha Ltd. and Gifu University | Date: 2011-04-06
[Technical Problem] To provide a novel imino derivative capable of being an insecticide compound having excellent characteristics such as sustained effects and broad spectrum. [Solution to Problem] To provide an imino derivative represented by Formula (1)._(2), NR; R denotes a hydrogen atom or an alkyl group; Y is selected from COR_(1) or CONR_(3)R_(4), CONHCOR_(5), CO_(2)R_(9); and each of R_(1), R_(3), R_(4), R_(5), and R_(9) denotes a hydrogen atom or a certain substituent.
Meiji Seika Kaisha Ltd. | Date: 2015-12-29
A new metallo--lactamase inhibitor which acts as a medicament for inhibiting the inactivation of -lactam antibiotics and recovering anti-bacterial activities is disclosed. The maleic acid derivatives having the general formula (I) have metallo--lactamase inhibiting activities. It is possible to recover the anti-bacterial activities of -lactam antibiotics against metallo--lactamase producing bacteria by combining the compound of the general formula (I) with -lactam antibiotics.
Nippon Kayaku Co. and Meiji Seika Kaisha Ltd. | Date: 2011-04-06
Disclosed is a process for producing 6-aryloxyquinoline derivatives useful as insecticides or fungicides for agricultural and horticultural use. The process comprises a cyclization reaction step of reacting an anthranilic acid derivative represented by general formula (1) with a kenone in the presence of an acid to obtain a quinolone derivative and a condensation reaction step of reacting the quinolone derivative with a halogen compound or an acid anhydride to obtain a quinoline derivative.
Meiji Seika Kaisha Co. | Date: 2016-09-06
The present invention relates to novel aminoglycoside antibiotics, a process for producing the same, and pharmaceutical use thereof. More specifically, the present invention relates to compounds represented by formula (I), a process for producing the same, and use of the same as antimicrobial agents. wherein R represents amino or hydroxyl.
Meiji Seika Kaisha Ltd. | Date: 2011-05-11
An isolated novel polynucleotide comprising a nucleotide sequence encoding at least one polypeptide involved in biosynthesis of pyripyropene A, a recombinant vector comprising the polynucleotide and a transformant comprising the polynucleotide are disclosed. By the present invention, a pyripyropene A biosynthetic gene useful for production of a novel pyripyropene analog, improvement of productivity of a pyripyropene A-producing bacterium, production of an insecticidal agent for microorganisms, creation of a plant resistant to insect pests or the like are provided.
Meiji Seika Kaisha Ltd. | Date: 2011-03-23
The present invention relates to a process for efficiently amplifying a giant DNA. More particularly, the present invention relates to a process for amplifying DNA in a cell, comprising amplifying the DNA as the target of amplification in the presence of DNAs selected from the following (i), (ii) and (iii):(i) DNA encoding a protein selected from the following 1), 2) and 3):1) a protein consisting of the amino acid sequence of SEQ ID NO: 1,2) a protein comprising an amino acid sequence which has a deletion, substitution, insertion or addition of one or more amino acids in the amino acid sequence of SEQ ID NO: 1, and3) a protein comprising an amino acid sequence which has an identity of 90% or more to the amino acid sequence of SEQ ID NO: 1,(ii) DNA consisting of the nucleotide sequence of SEQ ID NO: 2, and(iii) DNA hybridizing to the nucleotide sequence of SEQ ID NO: 2 under stringent conditions.
Meiji Seika Kaisha Ltd. | Date: 2011-06-08
A method for suppressing a reduction in an endoglucanase activity in the presence of a surfactant, characterized by modifying a protein having the endoglucanase activity in which the N-terminus is an amino acid other than pyroglutamic acid, to a protein having the N-terminus of pyroglutamic acid, is disclosed. Further, a modified protein having an endoglucanase activity wherein the N-terminal amino acid is converted into pyroglutamic acid by an amino acid modification, a polynucleotide encoding the protein, an expression vector comprising the polynucleotide, a host cell transformed with the expression vector, and a process for producing the protein by cultivating the host cell, are disclosed.